A 9-year-old female crossbred dog was referred due to a tongue neoformation. A marginal resection was performed to proceed with the histopathological examination, which indicated malignant round cell neoplasia, and immunohistochemical staining diagnosed the mass as plasmacytoma. The owner refused another surgical intervention to extend margins and approach another growth verified on the ventral surface of the base of the tongue. Thus, the patient underwent three months of metronomic chemotherapy with melphalan. The disease progression was not detected after two years of follow-up. This report shows that daily low-dose melphalan may be used as an adjuvant treatment option for oral plasmacytoma in dogs when clean margins cannot be achieved.
This work was supported by Coordination for the Improvement of Higher Education Personnel (CAPES), Brazil (Financing Code 001).
The authors thank for the support of the Coordination for the Improvement of Higher Education Personnel (CAPES), Brazil.
| Primary Language | English |
|---|---|
| Subjects | Veterinary Surgery, Veterinary Medicine |
| Journal Section | Case Report |
| Authors | |
| Early Pub Date | March 19, 2024 |
| Publication Date | January 1, 2025 |
| DOI | https://doi.org/10.33988/auvfd.1297530 |
| IZ | https://izlik.org/JA52JJ45DF |
| Published in Issue | Year 2025 Volume: 72 Issue: 1 |